Oct 20, 2026
1:7
For every 7 shares held, investors received 1. The price per share adjusted from $0.07 to $0.01.
The split itself did not change the total investment value.
Revelation Biosciences, Inc. (REVB) trades on the NASDAQ Capital Market in the Biotechnology industry.
Revelation Biosciences, Inc. company overviewThe latest split shown was on October 20, 2026. It was a 1-for-7 reverse split, so shareholders received 1 share for every 7 they held.
This history records 6 reverse splits between February 1, 2023 and October 20, 2026.